MDA5型
RNA沉默
阿达尔
RNA编辑
核糖核酸
生物
干扰素
细胞生物学
TLR3型
基因沉默
RNA结合蛋白
RNA干扰
遗传学
先天免疫系统
基因
受体
Toll样受体
作者
Jacki Heraud-Farlow,Scott Taylor,Alistair M. Chalk,Adriana Escudero,Shi-Bin Hu,Ankita Goradia,Tao Sun,Qin Li,Iva Nikolić,Jin Billy Li,Miguel Fidalgo,Diana Guallar,Kaylene J. Simpson,Carl R. Walkley
出处
期刊:Science immunology
[American Association for the Advancement of Science]
日期:2024-11-22
卷期号:9 (101)
被引量:1
标识
DOI:10.1126/sciimmunol.adk0412
摘要
Adenosine-to-inosine (A-to-I) editing of double-stranded RNA (dsRNA) by ADAR1 is an essential modifier of the immunogenicity of cellular dsRNA. The role of MDA5 in sensing unedited cellular dsRNA and the downstream activation of type I interferon (IFN) signaling are well established. However, we have an incomplete understanding of pathways that modify the response to unedited dsRNA. We performed a genome-wide CRISPR screen and showed that GGNBP2, CNOT10, and CNOT11 interact and regulate sensing of unedited cellular dsRNA. We found that GGNBP2 acts between dsRNA transcription and its cytoplasmic sensing by MDA5. GGNBP2 loss prevented induction of type I IFN and autoinflammation after the loss of ADAR1 editing activity by modifying the subcellular distribution of endogenous A-to-I editing substrates and reducing cytoplasmic dsRNA load. These findings reveal previously undescribed pathways to modify diseases associated with ADAR mutations and may be determinants of response or resistance to small-molecule ADAR1 inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI